The Market Aktie

The Market für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A3E16Q / ISIN: AU0000306037

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
20.08.2024 22:46:42

Why Eli Lilly Topped the Market on Tuesday

The U.S. pharmaceutical stock of the moment, Eli Lilly (NYSE: LLY), did rather well on Tuesday. Its price closed the day more than 3% higher, on the back of some good news from the lab about its hottest product. What also helped was a glowing new research note from an analyst. The stock's performance looked even better when matched against that of the S&P 500 index, which dipped by 0.2%.That hot product is obesity treatment Zepbound, Eli Lilly's entry in the white-hot weight loss drugs market. The pharmaceutical giant announced that in a clinical trial, the molecule significantly cut the risk of vulnerable individuals developing type 2 diabetes by 94%. Those individuals were either in a pre-diabetes stage, or were obese or overweight.Zepbound also did well as a weight loss treatment. Patients dosed with the drug experienced a nearly 23% average decrease in body weight. That compared very favorably with an average of 2% for patients taking a placebo.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu Eli Lillymehr Analysen

20.12.24 Eli Lilly Buy Jefferies & Company Inc.
31.10.24 Eli Lilly Buy Jefferies & Company Inc.
13.02.24 Eli Lilly Buy Jefferies & Company Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Eli Lilly 722,00 -4,28% Eli Lilly